The STOP-Bang screen & who should test
Eight yes-or-no questions, under a minute to answer, and a surprisingly good read on whether your sleep is quietly falling apart. This page walks through the STOP-Bang screen item by item — what it catches, what it misses, and the uncomfortable truth that a silent bedroom does not clear you of sleep apnea.
What the evidence supports
- STOP-Bang is the most-studied sleep apnea screen; a score of 3+ catches the large majority of moderate-to-severe cases across meta-analyses.
- Scores of 5–8 carry a strong probability of at least moderate OSA; scores of 0–2 make it unlikely but do not exclude it.
- High-risk conditions (resistant hypertension, atrial fibrillation, type 2 diabetes) warrant evaluation even when the score is low.
What remains uncertain
- Exact probability cutoffs vary by sex, age, and setting — the score is a triage tool, not a verdict.
- Self-reported answers are less reliable than partner-observed ones, especially for snoring and witnessed pauses.
- Whether screening symptom-free people changes long-term outcomes has not been established.
Evidence last reviewed: August 15, 2026. Conclusions may change as new research is published.
eight questions and a tape measure
Why a Screen Exists at All
The numbers make the case. Roughly a billion adults worldwide are estimated to have obstructive sleep apnea, the large majority undiagnosed (Benjafield et al., Lancet Respiratory Medicine, 2019) — and the parent topic Sleep Apnea: The Under-Diagnosed Risk lays out why the condition hides so well. The bottleneck is diagnosis itself: lab sleep studies are limited capacity, and most primary-care visits never mention sleep. A cheap, fast paper tool — one a clinic can hand over in the waiting room — exists to solve the triage problem: deciding who is worth the time, money, and equipment of a sleep study. That is the whole job of STOP-Bang. It does not diagnose. It ranks.
The Eight Questions, Line by Line
STOP-Bang is an acronym; each letter is a yes/no question worth one point. The original was developed for pre-operative screening (Chung et al., Anesthesiology, 2008) and later refined (Chung et al., Chest, 2016). Here is what each item is really probing:
| Item | The question | What it's really asking |
|---|---|---|
| S | Do you snore loudly (louder than talking, heard through a door)? | Airway turbulence — but absence proves little, as below. |
| T | Do you often feel tired, fatigued, or sleepy during the day? | The sleep debt of a night spent fighting your airway. |
| O | Has anyone observed you stop breathing or choke/gasp during sleep? | Witnessed apneas — the strongest item, invisible to solo sleepers. |
| P | Do you have or are you being treated for high blood pressure? | Apnea and hypertension travel together. |
| B | BMI above 35? | Weight is the strongest single risk factor — but not a requirement. |
| A | Age over 50? | Prevalence climbs steeply in midlife. |
| N | Neck circumference over 43 cm (17 in) if male, 41 cm (16 in) if female? | Throat tissue crowding — measure at the Adam's apple. |
| G | Gender: male? | Men carry higher risk at any weight; women are under-flagged, not protected. |
Notice the structure: four items are about symptoms, four are about risk factors. A person with no symptoms but four risk factors scores the same as a person with four symptoms and no risk factors — deliberately, because both profiles produce real disease.
Scoring: What the Tiers Mean
The conventional reading, from the validation literature, sorts scores into three tiers: 0–2 (low risk), 3–4 (intermediate), and 5–8 (high risk). The probability of moderate-to-severe OSA rises steeply through the range — the curve below is illustrative, but the shape is well supported by the meta-analyses in the sources.
Two honest caveats. First, the screen is designed to over-call: at the popular cutoff of 3+, sensitivity is high but specificity is modest, so plenty of people referred on a score of 3–4 turn out not to have apnea. That is a feature, not a bug — a screen should catch, and the sleep study sorts. Second, the tiers are probabilities, not boundaries: a person with a score of 2 and hard symptoms (morning headaches, unrefreshing sleep, treatment-resistant hypertension) has a higher pretest probability than the number alone suggests. The score refines judgment; it does not replace it.
Why "I Don't Snore" Does Not Rule Apnea Out
The most common self-dismissal in sleep medicine is also the flimsiest. Here is why the absence of snoring — or the absence of any noisy sign — settles nothing:
- 🤫 Snoring is one item of eight. The screen has seven other questions precisely because no single symptom is required. You can score 4 without snoring — and plenty of people do.
- 🙋 Hypopneas are quiet. Many events are shallow-breathing episodes rather than full airway closures. Airflow drops by half or more and oxygen follows — without the acoustic drama.
- 👩 Women snore less and get missed more. Across cohorts, women report snoring and witnessed pauses less often than men at the same AHI — a core reason their cases are under-flagged (see Not just obesity for the full profile).
- 🛌 You cannot hear yourself. The snoring item is validated against partner observation. If you sleep alone, the two most informative items (S and O) are effectively unscorable.
- 📐 Anatomy without acoustics. Young, lean people with narrow jaws and crowded throats can have severe disease with minimal snoring — the airway narrows to a slit and airflow falls without flapping tissue. The N item (neck circumference) exists for the people the S item misses.
The summary is blunt: self-reported "I don't snore" has a real false-reassurance rate. If the other items — fatigue, hypertension, weight, neck size, age — add up, the quiet bedroom proves nothing.
Who Should Test Even With a Low Score
The screen is one route in; the other is the condition list. Several diagnoses are so entangled with apnea that guidelines treat them as reasons to evaluate almost regardless of score:
- 💓 Resistant hypertension. Blood pressure that stays high on three drugs is a classic apnea marker — the Blood Pressure protocol flags it directly.
- 🫀 Atrial fibrillation. Apnea is a major reversible contributor to AF recurrence — see Apnea's metabolic toll.
- 🩸 Type 2 diabetes or prediabetes. Untreated apnea worsens glucose control independent of weight — the Glucose 101 page owns the blood-sugar side.
- 🚽 Nocturia and morning headaches. Two or more nightly bathroom trips and regular dawn headaches are underrated apnea signals.
- 🚩 Sleepiness that has no habit explanation. If the sleepiness red flags apply, evaluation is warranted even with a STOP-Bang of 2.
- 🚚 Occupational and pre-operative settings. Commercial drivers with sleepiness, and anyone heading into major surgery, are screened aggressively because the stakes of a missed case are immediate.
⚠️ A screen is not a diagnosis
No score on this page diagnoses sleep apnea, and nothing here replaces a sleep study interpreted by a clinician. The riskier failure mode is self-treatment: buying a used machine and dialing in pressures yourself skips the differential diagnosis — central apnea, alcohol effects, and other mimics need different answers. If your score or symptoms point this way, take the result to a qualified professional, not to an online marketplace.
What Happens After a Positive Screen
A score of 3+, or a high-risk condition from the list above, routes to the same next step: a clinician conversation, then a sleep study. For most uncomplicated cases that means a home sleep test; for complex presentations — suspected central apnea, heart failure, neurological disease, or an inconclusive home result — a lab polysomnography. The trade-offs between the two are exactly what Home sleep tests vs lab polysomnography walks through. What matters now is the sequence: screen first, study second, and treat from your actual AHI number — not from a hunch.
Questions, Answered Briefly
- 📋 Can I score myself? Yes, with one fix: ask a bed partner (or record yourself) for the snoring and witnessed-pause items. Self-report alone underweights the two most informative questions.
- 🎯 What score means "get tested"? 3+ in most settings; 5+ strongly. Below that, let symptoms and the condition list — not the number — decide.
- ⌚ My smartwatch shows oxygen dips — does that count? A consumer SpO2 trace is not a sleep study and can both over- and under-call. But a consistent pattern of dips is a legitimate reason to get the real test.
- 🧮 I scored 8. Am I doomed? High scores mean high probability of moderate-to-severe disease — and unusually good treatment odds, because treatable apnea is among the most reversible diagnoses in medicine. The Beyond CPAP page covers what happens next.
The Bottom Line
- Take the screen seriously but not literally. It is the most validated apnea triage tool — and still just a triage tool.
- Score 3+ (or a high-risk condition) means: clinician, then study. The home-vs-lab choice is secondary; not testing is the actual mistake.
- Retire "I don't snore" as a defense. One item of eight cannot clear you, especially if you sleep alone or are a woman.
- Use the condition list as a second screen. Resistant hypertension, AF, and diabetes are apnea's calling cards even at low scores.
Related Topics
- Chung et al., "STOP questionnaire: a tool to screen patients for obstructive sleep apnea," Anesthesiology (2008)
- Chung et al., "STOP-Bang questionnaire: a practical approach to screen for obstructive sleep apnea," Chest (2016)
- Nagappa et al., "Validation of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnea among different populations: a systematic review and meta-analysis," PLoS One (2015)
- Young et al., "The occurrence of sleep-disordered breathing among middle-aged adults," NEJM (1993)
- Benjafield et al., "Estimation of the global prevalence and burden of obstructive sleep apnoea," The Lancet Respiratory Medicine (2019)
- Johns, "A new method for measuring daytime sleepiness: the Epworth sleepiness scale," Sleep (1991)
- Kapur et al., "Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea," Journal of Clinical Sleep Medicine (2017)